BA
OPTR

BlackRock Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-30,304
Closed -$382K – 3710
2013
Q3 		$382K Buy
30,304
+919
+3% +$12.2K ﹤0.01% 2124
2013
Q2 		$425K Buy
+29,385
New +$428K ﹤0.01% 1949

BlackRock Advisors's OPTR Position: Q4 2013 in Review

BlackRock Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 30,304 shares — an estimated $382K sold.

BlackRock Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $425K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock Advisors sold 30,304 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $382K.
  • BlackRock Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $425K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.